AiMedic Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 29

Employees

  • Latest Deal Type
  • Series A

  • Investors
  • 10

AiMedic General Information

Description

Developer of diagnostic tools designed to treat coronary diseases. The company offers artificial intelligence and simulation-based tools with medical image analysis, automated segmentation, physiological modeling, and functional assessment tools to assist in the diagnosis and treatment planning of cardiovascular conditions, enabling healthcare providers such as clinicians and radiologists to evaluate cardiac conditions accurately and support informed clinical decisions.

Contact Information

Website
www.aimedic.kr
Formerly Known As
Silicon Sapiens, Basque system, Vask System
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 7th Floor, 326 Dosan-daero, Nonhyeon-dong
  • Gangnam-gu
  • Seoul, 06097
  • South Korea
+82
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 7th Floor, 326 Dosan-daero, Nonhyeon-dong
  • Gangnam-gu
  • Seoul, 06097
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AiMedic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A) 11-Oct-2023 Completed Generating Revenue
4. Later Stage VC (Series A) 29-Feb-2020 Completed Generating Revenue
3. Seed Round 30-Apr-2018 Completed Generating Revenue
2. Accelerator/Incubator 01-Oct-2016 $449K Completed Generating Revenue
1. Seed Round 31-Aug-2016 $449K $449K Completed Generating Revenue
To view AiMedic’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

AiMedic Patents

AiMedic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11145224-B2 Blood flow simulation method and apparatus for subject-specific blood vessel Active 15-Oct-2019
US-20210256877-A1 Blood flow simulation method and apparatus for subject-specific blood vessel Active 15-Oct-2019
EP-3836146-A1 Method and apparatus for simulating blood flow of subject-specific blood vessel Active 15-Oct-2019
EP-3836146-A4 Method and apparatus for simulating blood flow of subject-specific blood vessel Active 15-Oct-2019
EP-3836146-B1 Method and apparatus for simulating blood flow of subject-specific blood vessel Active 15-Oct-2019 G16H50/50
To view AiMedic’s complete patent history, request access »

AiMedic Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AiMedic Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Entels Corporation Minority
KB Investment Venture Capital Minority
Lifecore Partners Venture Capital Minority
S Ventures (Korea) Venture Capital Minority
InterValue Partners Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

AiMedic FAQs

  • When was AiMedic founded?

    AiMedic was founded in 2014.

  • Where is AiMedic headquartered?

    AiMedic is headquartered in Seoul, South Korea.

  • What is the size of AiMedic?

    AiMedic has 29 total employees.

  • What industry is AiMedic in?

    AiMedic’s primary industry is Diagnostic Equipment.

  • Is AiMedic a private or public company?

    AiMedic is a Private company.

  • What is AiMedic’s current revenue?

    The current revenue for AiMedic is .

  • How much funding has AiMedic raised over time?

    AiMedic has raised $10.8M.

  • Who are AiMedic’s investors?

    Entels, KB Investment, Lifecore Partners, S Ventures (Korea), and InterValue Partners are 5 of 10 investors who have invested in AiMedic.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process